India Premature Labor Treatment Market Research Report 2018

Publisher Name :
Date: 12-Apr-2018
No. of pages: 102
Inquire Before Buying

The global Premature Labor Treatment market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

India plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Premature Labor Treatment development status and future trend in India, focuses on top players in India, also splits Premature Labor Treatment by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

The major players in India market include

- AMAG Pharmaceuticals Inc

- GlaxoSmithKline Plc

- Juniper Pharmaceuticals Inc

- Kissei Pharmaceutical Co Ltd

- Lipocine Inc

- ObsEva SA

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

- Progesterone

- OBE-022

- Retosiban

- Others

On the basis of the end users/Application, this report covers

- Hospital

- Clinic

- Others

If you have any special requirements, please let us know and we will offer you the report as you want.

India Premature Labor Treatment Market Research Report 2018

Table of Contents
India Premature Labor Treatment Market Research Report 2018
1 Premature Labor Treatment Overview
1.1 Product Overview and Scope of Premature Labor Treatment
1.2 Classification of Premature Labor Treatment by Product Category
1.2.1 India Premature Labor Treatment Sales (K Pcs) Comparison by Type (2013-2025)
1.2.2 India Premature Labor Treatment Sales (K Pcs) Market Share by Type in 2017
1.2.3 Progesterone
1.2.4 OBE-022
1.2.5 Retosiban
1.2.6 Others
1.3 India Premature Labor Treatment Market by Application/End Users
1.3.1 India Premature Labor Treatment Sales (K Pcs) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 India Revenue and Sales of Premature Labor Treatment (2013-2025)
1.4.1 India Premature Labor Treatment Sales (K Pcs) and Growth Rate (%)(2013-2025)
1.4.2 India Premature Labor Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
2 India Premature Labor Treatment Market Competition by Players/Manufacturers
2.1 India Premature Labor Treatment Sales (K Pcs) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 India Premature Labor Treatment Revenue and Share by Players/Manufacturers (2013-2018)
2.3 India Premature Labor Treatment Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 India Premature Labor Treatment Market Competitive Situation and Trends
2.4.1 India Premature Labor Treatment Market Concentration Rate
2.4.2 India Premature Labor Treatment Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in India Market
2.5 India Players/Manufacturers Premature Labor Treatment Manufacturing Base Distribution, Sales Area, Product Type
3 India Premature Labor Treatment Sales and Revenue (Value) by Type (2013-2018)
3.1 India Premature Labor Treatment Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
3.2 India Premature Labor Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 India Premature Labor Treatment Price (USD/Pcs) by Type (2013-2018)
3.4 India Premature Labor Treatment Sales Growth Rate (%) by Type (2013-2018)
4 India Premature Labor Treatment Sales by Application (2013-2018)
4.1 India Premature Labor Treatment Sales (K Pcs) and Market Share by Application (2013-2018)
4.2 India Premature Labor Treatment Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities
5 India Premature Labor Treatment Players/Suppliers Profiles and Sales Data
5.1 AMAG Pharmaceuticals Inc
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Premature Labor Treatment Product Category, Application and Specification
5.1.2.1 Product A
5.1.2.2 Product B
5.1.3 AMAG Pharmaceuticals Inc Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.1.4 Main Business/Business Overview
5.2 GlaxoSmithKline Plc
5.2.1 Company Basic Information, Manufacturing Base and Competitors
5.2.2 Premature Labor Treatment Product Category, Application and Specification
5.2.2.1 Product A
5.2.2.2 Product B
5.2.3 GlaxoSmithKline Plc Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.2.4 Main Business/Business Overview
5.3 Juniper Pharmaceuticals Inc
5.3.1 Company Basic Information, Manufacturing Base and Competitors
5.3.2 Premature Labor Treatment Product Category, Application and Specification
5.3.2.1 Product A
5.3.2.2 Product B
5.3.3 Juniper Pharmaceuticals Inc Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.3.4 Main Business/Business Overview
5.4 Kissei Pharmaceutical Co Ltd
5.4.1 Company Basic Information, Manufacturing Base and Competitors
5.4.2 Premature Labor Treatment Product Category, Application and Specification
5.4.2.1 Product A
5.4.2.2 Product B
5.4.3 Kissei Pharmaceutical Co Ltd Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.4.4 Main Business/Business Overview
5.5 Lipocine Inc
5.5.1 Company Basic Information, Manufacturing Base and Competitors
5.5.2 Premature Labor Treatment Product Category, Application and Specification
5.5.2.1 Product A
5.5.2.2 Product B
5.5.3 Lipocine Inc Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.5.4 Main Business/Business Overview
5.6 ObsEva SA
5.6.1 Company Basic Information, Manufacturing Base and Competitors
5.6.2 Premature Labor Treatment Product Category, Application and Specification
5.6.2.1 Product A
5.6.2.2 Product B
5.6.3 ObsEva SA Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.6.4 Main Business/Business Overview
6 Premature Labor Treatment Manufacturing Cost Analysis
6.1 Premature Labor Treatment Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Premature Labor Treatment
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Premature Labor Treatment Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Premature Labor Treatment Major Manufacturers in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 India Premature Labor Treatment Market Size (Sales and Revenue) Forecast (2018-2025)
10.1 India Premature Labor Treatment Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
10.2 India Premature Labor Treatment Sales (K Pcs) Forecast by Type (2018-2025)
10.3 India Premature Labor Treatment Sales (K Pcs) Forecast by Application (2018-2025)
11 Research Findings and Conclusion
List of Tables and Figures
Figure India Market Size (Million USD) Status and Outlook (2013-2025)
Table Premature Labor Treatment Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Premature Labor Treatment Sales (K Pcs) by Application (2017-2025)
Figure Product Picture of Premature Labor Treatment
Table India Premature Labor Treatment Sales (K Pcs) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)
Figure India Premature Labor Treatment Sales Volume Market Share by Type in 2017
Figure Progesterone Product Picture
Figure OBE-022 Product Picture
Figure Retosiban Product Picture
Figure Others Product Picture
Figure India Premature Labor Treatment Sales (K Pcs) Comparison by Application (2013-2025)
Figure India Sales Market Share (%) of Premature Labor Treatment by Application in 2017
Figure Hospital Examples
Figure Clinic Examples
Figure Others Examples
Figure India Premature Labor Treatment Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure India Premature Labor Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table India Premature Labor Treatment Sales of Key Players/Manufacturers (2013-2018)
Table India Premature Labor Treatment Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 India Premature Labor Treatment Sales Share (%) by Players/Manufacturers
Figure 2017 India Premature Labor Treatment Sales Share (%) by Players/Manufacturers
Table India Premature Labor Treatment Revenue by Players/Manufacturers (2013-2018)
Table India Premature Labor Treatment Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 India Premature Labor Treatment Revenue Share (%) by Players/Manufacturers
Figure 2017 India Premature Labor Treatment Revenue Share (%) by Players/Manufacturers
Table India Market Premature Labor Treatment Average Price (USD/Pcs) of Key Players/Manufacturers (2013-2018)
Figure India Market Premature Labor Treatment Average Price (USD/Pcs) of Key Players/Manufacturers in 2017
Figure India Premature Labor Treatment Market Share of Top 3 Players/Manufacturers
Figure India Premature Labor Treatment Market Share of Top 5 Players/Manufacturers
Table India Players/Manufacturers Premature Labor Treatment Manufacturing Base Distribution and Sales Area
Table India Players/Manufacturers Premature Labor Treatment Product Category
Table India Premature Labor Treatment Sales (K Pcs) by Type (2013-2018)
Table India Premature Labor Treatment Sales Share (%) by Type (2013-2018)
Figure India Premature Labor Treatment Sales Share (%) by Type (2013-2018)
Figure India Premature Labor Treatment Sales Market Share (%) by Type in 2017
Table India Premature Labor Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
Table India Premature Labor Treatment Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Premature Labor Treatment by Type (2013-2018)
Figure Revenue Market Share of Premature Labor Treatment by Type in 2017
Table India Premature Labor Treatment Price (USD/Pcs) by Type (2013-2018)
Figure India Premature Labor Treatment Sales Growth Rate (%) by Type (2013-2018)
Table India Premature Labor Treatment Sales (K Pcs) by Application (2013-2018)
Table India Premature Labor Treatment Sales Market Share (%) by Application (2013-2018)
Figure India Premature Labor Treatment Sales Market Share (%) by Application (2013-2018)
Figure India Premature Labor Treatment Sales Market Share (%) by Application in 2017
Table India Premature Labor Treatment Sales Growth Rate (%) by Application (2013-2018)
Figure India Premature Labor Treatment Sales Growth Rate (%) by Application (2013-2018)
Table AMAG Pharmaceuticals Inc Premature Labor Treatment Basic Information List
Table AMAG Pharmaceuticals Inc Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure AMAG Pharmaceuticals Inc Premature Labor Treatment Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure AMAG Pharmaceuticals Inc Premature Labor Treatment Sales Market Share (%) in India (2013-2018)
Figure AMAG Pharmaceuticals Inc Premature Labor Treatment Revenue Market Share (%) in India (2013-2018)
Table GlaxoSmithKline Plc Premature Labor Treatment Basic Information List
Table GlaxoSmithKline Plc Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure GlaxoSmithKline Plc Premature Labor Treatment Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure GlaxoSmithKline Plc Premature Labor Treatment Sales Market Share (%) in India (2013-2018)
Figure GlaxoSmithKline Plc Premature Labor Treatment Revenue Market Share (%) in India (2013-2018)
Table Juniper Pharmaceuticals Inc Premature Labor Treatment Basic Information List
Table Juniper Pharmaceuticals Inc Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Juniper Pharmaceuticals Inc Premature Labor Treatment Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Juniper Pharmaceuticals Inc Premature Labor Treatment Sales Market Share (%) in India (2013-2018)
Figure Juniper Pharmaceuticals Inc Premature Labor Treatment Revenue Market Share (%) in India (2013-2018)
Table Kissei Pharmaceutical Co Ltd Premature Labor Treatment Basic Information List
Table Kissei Pharmaceutical Co Ltd Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Kissei Pharmaceutical Co Ltd Premature Labor Treatment Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Kissei Pharmaceutical Co Ltd Premature Labor Treatment Sales Market Share (%) in India (2013-2018)
Figure Kissei Pharmaceutical Co Ltd Premature Labor Treatment Revenue Market Share (%) in India (2013-2018)
Table Lipocine Inc Premature Labor Treatment Basic Information List
Table Lipocine Inc Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Lipocine Inc Premature Labor Treatment Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Lipocine Inc Premature Labor Treatment Sales Market Share (%) in India (2013-2018)
Figure Lipocine Inc Premature Labor Treatment Revenue Market Share (%) in India (2013-2018)
Table ObsEva SA Premature Labor Treatment Basic Information List
Table ObsEva SA Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure ObsEva SA Premature Labor Treatment Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure ObsEva SA Premature Labor Treatment Sales Market Share (%) in India (2013-2018)
Figure ObsEva SA Premature Labor Treatment Revenue Market Share (%) in India (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Premature Labor Treatment
Figure Manufacturing Process Analysis of Premature Labor Treatment
Figure Premature Labor Treatment Industrial Chain Analysis
Table Raw Materials Sources of Premature Labor Treatment Major Players/Manufacturers in 2017
Table Major Buyers of Premature Labor Treatment
Table Distributors/Traders List
Figure India Premature Labor Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure India Premature Labor Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Premature Labor Treatment Price (USD/Pcs) Trend Forecast (2018-2025)
Table India Premature Labor Treatment Sales (K Pcs) Forecast by Type (2018-2025)
Figure India Premature Labor Treatment Sales (K Pcs) Forecast by Type (2018-2025)
Figure India Premature Labor Treatment Sales Volume Market Share Forecast by Type in 2025
Table India Premature Labor Treatment Sales (K Pcs) Forecast by Application (2018-2025)
Figure India Premature Labor Treatment Sales Volume Market Share Forecast by Application (2018-2025)
Figure India Premature Labor Treatment Sales Volume Market Share Forecast by Application in 2025
  • Global Decoagulant Market Insights, Forecast to 2025
    Published: 19-Oct-2018        Price: US 3900 Onwards        Pages: 113
    In 2017, the global Decoagulant market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Decoagulant market based on company, product type, application and key regions. This report studies the global market size of Decoagulant in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumptio......
  • Global Drug Excipients Market Insights, Forecast to 2025
    Published: 19-Oct-2018        Price: US 3900 Onwards        Pages: 110
    In 2017, the global Drug Excipients market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Drug Excipients market based on company, product type, application and key regions. This report studies the global market size of Drug Excipients in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on th......
  • Global 3D Cell Culture System Market Insights, Forecast to 2025
    Published: 19-Oct-2018        Price: US 3900 Onwards        Pages: 129
    In 2017, the global 3D Cell Culture System market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the 3D Cell Culture System market based on company, product type, application and key regions. This report studies the global market size of 3D Cell Culture System in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & ......
  • Global Opioid Induced Constipation (OIC) Drug Market Insights, Forecast to 2025
    Published: 19-Oct-2018        Price: US 3900 Onwards        Pages: 125
    Opioid-induced constipation (OIC) is a common adverse effect experienced by many patients on opioid therapy for chronic pain. OTC medications include stimulant laxatives, stool softeners, and enemas. In 2017, the global Opioid Induced Constipation (OIC) Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Opioid Induced Constipation (OIC) Drug marke......
  • Global IBS-C Drug Market Insights, Forecast to 2025
    Published: 19-Oct-2018        Price: US 3900 Onwards        Pages: 128
    IBS-C is defined as belly pain (abdominal pain) associated with constipation. The symptoms of IBS-C are defined as long-lasting and keep coming back. Those suffering from IBS-C also have hard or lumpy stools at least 25% of the time, and loose or watery stools less than 25% of the time. The important driver increasing growth in the Global Irritable Bowel Syndrome with Constipation drugs Market are modern dietary habits that are having adverse effects on the human body. Some of the dietary......
  • Global Anti-Depressant Market Insights, Forecast to 2025
    Published: 19-Oct-2018        Price: US 3900 Onwards        Pages: 118
    Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive-compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications. In 2017, the global Anti-Depressant market size was xx ......
  • Global Paediatric Vaccine Market Insights, Forecast to 2025
    Published: 19-Oct-2018        Price: US 3900 Onwards        Pages: 117
    Vaccine provides protection against particular diseases by improving immunity. Vaccines are the biological preparations of weakened or killed microorganism, its surface proteins or its toxins. The global paediatric vaccine market is expected to grow at a healthy CAGR in next few years. Increase in growth would be primarily attributed to improved understanding of immunology, which has resulted in launch of new vaccines products. Technological breakthrough has led to development of ......
  • Global Atipamezole Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Oct-2018        Price: US 3480 Onwards        Pages: 128
    Scope of the Report: This report focuses on the Atipamezole in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Atipamezole is a synthetic alpha 2 adrenergic receptor antagonist drug, which reverses the effects of sedative and analgesic drugs such as medetomidine, xylazine, amitraz, and detomidine among ......
  • Global Bone Glues Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Oct-2018        Price: US 3480 Onwards        Pages: 129
    Bone glues are a form of collagen. They are obtained from animal sources such as bovine and piscine bones. The most commonly used production process for making bone glues involves the procurement of animal bones from slaughterhouses, tanneries, and meat packing companies and their subjection to washing, boiling under pressure, de-mineralization and extraction of collagen, and drying. Scope of the Report: This report focuses on the Bone Glues in global market, especi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs